Refine
Has Fulltext
- yes (18) (remove)
Is part of the Bibliography
- yes (18) (remove)
Year of publication
Document Type
- Journal article (10)
- Doctoral Thesis (8)
Keywords
- diabetes (18) (remove)
Institute
- Medizinische Klinik und Poliklinik I (8)
- Institut für Anatomie und Zellbiologie (2)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (2)
- Klinik und Poliklinik für Nuklearmedizin (2)
- Graduate School of Life Sciences (1)
- Institut für Klinische Epidemiologie und Biometrie (1)
- Institut für Pharmakologie und Toxikologie (1)
- Institut für Pharmazie und Lebensmittelchemie (1)
- Lehrstuhl für Tissue Engineering und Regenerative Medizin (1)
- Medizinische Klinik und Poliklinik II (1)
EU-Project number / Contract (GA) number
- 701983 (1)
The incidence of cardiovascular and metabolic diseases has increased over the last decades and is an important cause of death worldwide. An upcoming ingredient on the nutraceutical market are anthocyanins, a flavonoid subgroup, abundant mostly in berries and fruits. Epidemiological studies have suggested an association between anthocyanin intake and improved cardiovascular risk, type 2 diabetes and myocardial infarct. Clinical studies using anthocyanins have shown a significant decrease in inflammation markers and oxidative stress, a beneficial effect on vascular function and hyperlipidemia by decreasing low-density lipoprotein and increasing high-density lipoprotein. They have also shown a potential effect on glucose homeostasis and cognitive decline. This review summarizes the effects of anthocyanins in in-vitro, animal and human studies to give an overview of their application in medical prevention or as a dietary supplement.